Drug Profile
Mercaptopurine delayed-release - Teva
Alternative Names: Delayed Release 6 mercaptopurine - Teva; Delayed Release 6 MP - Teva; DR 6MPLatest Information Update: 16 Jan 2022
Price :
$50
*
At a glance
- Originator Teva Pharmaceutical Industries
- Class Antineoplastics; Purines; Small molecules; Sulfhydryl compounds
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Crohn's disease